News round-up for 5-9 October, 2026 by Megan Thomas, Multimedia Editor at DDW. This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Conference in London, as well as some promising updates in cancer research and immunotherapy, particularly the development of new treatments and how… Read More
This digital summit, hosted by DDW and supported by Sino Biological, explores the advances and challenges taking place within the field of immuno-oncology. It will take place on Wednesday, October 21, 2026 at 7am PDT / 10am EDT / 3pm BST / 4pm CEST. Featuring expert presentations and a panel… Read More
News round-up for 28 September – 2 October 2026 by Megan Thomas, Content Team at DDW. This week’s news roundup covers the upcoming the Drug Discovery Innovators & Investors Conference in London, as well as global updates on cancer research. The top stories: In-person… Read More
Results of an investigators’ Phase II clinical trial in vitamin C have been published by Wiley online in Cancer, a peer-reviewed journal of the American Cancer Society. Vitamin C boosts the activity of cellular proteins called TET enzymes that help control which genes are turned on or off. Because decreased… Read More
GSK has entered an agreement to acquire a potential best-in-class trispecific T cell-engager (TCE) from Chimagen Biosciences, a privately held biotechnology company. GSK plans to develop and commercialise the asset for multiple myeloma, with the programme expected to enter Phase I trials in 2027. TCEs have shown… Read More
This digital summit, hosted by DDW and supported by Sino Biological, explores the advances and challenges taking place within the field of immuno-oncology. Featuring expert presentations and a panel discussion, the summit will explore topics such as how to tackle cancer drug resistance, personalised medicine, cytotoxic therapy in the immunotherapy… Read More
This digital summit, hosted by DDW and supported by Sino Biological, explores the advances and challenges taking place within the field of immuno-oncology. Featuring expert presentations and a panel discussion, the summit will explore topics such as how to tackle cancer drug resistance, personalised medicine, cytotoxic therapy in the immunotherapy… Read More
News round-up for 21-25 September 2026 by Megan Thomas, Content Team at DDW. This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Digital Forum and the Drug Discovery Innovators & Investors Conference in London, as well as the latest developments in drug discovery,… Read More
Hosted by Drug Discovery World and supported by Sartorius and BioIVT, this webinar will explore the opportunities and challenges that exist within cancer research drug discovery and development. You will hear from Dr Sudha Rao, Chief Scientific Officer of Kazia Therapeutics, Karol Budzik, PhD, Business Development Associate at Vyriad Therapeutics… Read More
Hosted by Drug Discovery World and supported by Sartorius and BioIVT, this webinar will explore the opportunities and challenges that exist within cancer research drug discovery and development. You will hear from Dr Sudha Rao, Chief Scientific Officer of Kazia Therapeutics, Karol Budzik, PhD, Business Development Associate at Vyriad Therapeutics… Read More
News round-up for 14-18 September 2026 by Megan Thomas, Content Team at DDW. This week’s news roundup covers the upcoming Drug Discovery Innovators & Investors Digital Forum and the Drug Discovery Innovators & Investors Conference in London, changes to US scientific research grant screening, the UK’s… Read More
Hosted by Drug Discovery World and supported by Sartorius and BioIVT, this webinar will explore the opportunities and challenges that exist within cancer research drug discovery and development. You will hear from Karol Budzik, PhD, Business Development Associate at Vyriad Therapeutics and Lars van der Veen, Chief Scientific Officer at… Read More
News round-up for 7-11 September 2026 by Megan Thomas, Content Team at DDW. This week’s news roundup covers upcoming Drug Discovery Innovators & Investors (DDII) in-person events and forum updates, alongside the latest Phase II clinical data across coeliac disease, bronchiectasis and head and neck cancer. Read More
Hosted by Drug Discovery World and supported by Sartorius and BioIVT, this webinar will explore the opportunities and challenges that exist within cancer research drug discovery and development. You will hear from Dr Sudha Rao, Chief Scientific Officer of Kazia Therapeutics, Karol Budzik, PhD, Business Development Associate at Vyriad Therapeutics… Read More
News round-up for 31 August – 4 September 2026 by Megan Thomas, Content Team at DDW. This week’s news roundup covers new developments in vaccines, drug approvals, cardiovascular therapies and cancer drug response, alongside DDW’s upcoming digital forum focused on the technologies, strategies and investment trends shaping… Read More
